CVE-2026-31071 LalanaChami CVE debrief

Who should care

Organizations running the affected LalanaChami Pharmacy Management System codebase, especially teams exposing the backend API to untrusted networks, should treat this as urgent. Security, backend, DevOps, and application owners responsible for pharmacy, prescription, or patient-adjacent data should review it immediately.

Technical summary

The reported weakness is missing authentication middleware on backend API routes. The supplied description names at least /api/user/getUserData and /api/doctorOder as affected endpoints, with consequences that include bulk user-data disclosure, exposure of bcrypt password hashes, unauthorized inventory modification, and access to private medical prescription data. The NVD metadata in the supplied corpus associates the issue with CWE-306 and a CVSS vector of CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N.

Defensive priority

Critical. The issue enables unauthenticated network attackers to access sensitive records and modify operational data, so it should be prioritized for immediate containment, patching, and verification before normal backlog work.

Recommended defensive actions

• Add authentication and authorization checks to all sensitive API routes, not only the endpoints named in the advisory.
• Verify that user, inventory, and prescription handlers reject unauthenticated requests by default.
• Review the referenced backend routes at commit 5c3d028 and confirm no other endpoints are exposed without auth middleware.
• Rotate or invalidate credentials and secrets that may be affected by exposure of user records or password hashes.
• Assess whether exposed prescription or inventory data requires incident response, notification, or audit logging review.
• Deploy temporary network or reverse-proxy controls if a code fix cannot be applied immediately.
• Add regression tests to ensure sensitive routes fail closed when authentication middleware is missing or misconfigured.

Evidence notes

The CVE description supplied with the record states that API endpoints in LalanaChami Pharmacy Management System at commit 5c3d028 lack authentication middleware and can be abused to dump user records, modify inventory, and access prescription data. The NVD metadata in the supplied source item marks the vulnerability status as Deferred and lists CWE-306 as a secondary weakness. The referenced GitHub route tree and gist are the only supporting links provided in the corpus; no additional vendor confirmation is included.

Official resources